Receptor Antibodies as Novel Therapeutics for Diabetes

Fibroblast growth factors and their receptors in cancer

(2011) Jørgen Wesche et al.   BIOCHEMICAL JOURNAL

Physiological inhibitors of Wnt signaling

(2011) Alexandra Filipovich et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1

(2011) A.-L. Wu et al.   Science Translational Medicine

Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats

(2010) D. A. Sarruf et al.   DIABETES

Enterovirus RNA in Blood Is Linked to the Development of Type 1 Diabetes

(2010) S. Oikarinen et al.   DIABETES

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

(2010) f. M. Fisher et al.   DIABETES

Fibroblast growth factor 21: from pharmacology to physiology

(2009) Steven A Kliewer et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

TSH receptor autoantibodies

(2009) Krzysztof Michalek et al.   AUTOIMMUNITY REVIEWS

Autoimmune disorders of the neuromuscular junction

(2009) Bethan Lang et al.   CURRENT OPINION IN PHARMACOLOGY

Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible  -Cell Hyperplasia and Hyperglucagonemia

(2009) W. Gu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure

(2008) Yu-Hua Tseng et al.   NATURE